Studies of PLGA microspheres

Pharmaceutical Technology Europe

Volumn 16, Issue 5, 2004, Pages 23-34

  Dubey, Rajesh R ^a   Parikh, Rajesh H ^b  

^a Cadila Pharmaceutical Ltd   (India)

^b AR Patel and GH Patel Institute of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHITOSAN; METHOTREXATE; MICROSPHERE; POLYGLACTIN; POLYMER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; IN VITRO STUDY; LOW TEMPERATURE; MATHEMATICAL MODEL; PARTICLE SIZE; PROCESS TECHNOLOGY; SURFACE PROPERTY; SUSPENSION; TABLET COMPRESSION; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 8844274102     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. P.K. Gupta, C.T. Hung and F.C. Lam, "Applications of Particulate Carriers in Intratumoral Drug Delivery," in Pharmaceutical Particulate Carriers: Therapeutic Applications (Marcel Dekker, Inc., New York, New York, USA, 1999) pp 135-164.
2. T. Kato, "Encapsulated Drugs in Targeted Cancer' Therapy," in S.D. Bruck, Ed., Controlled Drug Delivery Vol. II: Clinical Applications (CRC Press, Boca Raton, Florida, USA, 1983) pp 189-240.
3. P.K. Gupta and C.T. Hung, "Albumin Microspheres II: Applications in Drug Delivery," J. Microencapsulation 6(4), 463-472 (1989).
4. A.K. Singla and M. Chawla, "Chitosan: Some Pharmaceutical and Biological Aspects - An Update," J. Pharm. Pharmacol. 53 8), 1047-1067 (2001).
5. H. Okada, "One- and Three-month Release Injectable Microspheres of the LH-RH Superagonist Leuprorelin Acetate," Adv. Drug Deliv. Rev. 28(1), 43-70 (1997).
6. B. Hutchinson and B.J.A. Furr, "Biodegradable Polymer Systems for the Sustained Release of Polypeptides," J. Control. Rel. 13(2-3), 279-294 (1990).
7. C. Thomasin, H.P. Merkle and B. Gander, "Drug Microencapsulation by PLA/PLGA Coacervation in the Light of Thermodynamics. II. Parameters Determining Microspheres Formation," J. Pharm. Sci. 87(3),269-275 (1998).
8. R. Jeyanthi et al., "Effect of Processing Parameters on the Properties of Peptide Containing PLGA Microspheres," J. Microencapsulation 14(2), 163-174 (1997).
9. F. Gabor et al., "Ketoprofen-poly(D,L-lactic-co-glycolic acid) Microspheres: Influence of Manufacturing Parameters and Type of Polymer on the Release Characteristics," J. Microencapsulation 16(1), 1-12 (1999).
10. B.A. Chabner et al., "Antineoplastic Agents," in J.G. Hardman et al., Eds., Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition (McGraw-Hill, Columbus, Ohio, USA, 1955) pp 1233-1288.
11. E.B. Denkbas, M. Seyyal and E. Piskin, "5-fluorouracil Loaded Chitosan Microspheres for Chemoembolization," J. Microencapsulation 16(6), 741-749 (1999).
12. R.H. Parikh et al., "Poly(D,L-lactide-coglycolide) Microspheres Containing 5-FU: Optimization of Process Parameters," AAPS PharmSciTech. 4(2), Article 13 (2003).
13. Y.S. Nam and T.G. Park, "Protein Loaded Biodegradable Microspheres Based on PLGA-protein Biconjugates," J. Microencapsulation 16(5), 625-637 (1999).
14. M. Boisdron-Celle, P.H. Menei and P. Benoit, "Preparation and Characterization of 5-FU-loaded Microparticles as Biodegradable Anticancer Drug Carriers," J. Pharm. Pharmacol. 47,108-114 (1995).